Cardiol Therapeutics Inc Class A (CRDL) — Financial Flexibility Index
Cardiol Therapeutics Inc Class A (CRDL) has a Financial Flexibility Index of -0.91x as of December 2025. Free cash flow of CA$-5.22 Million (operating CF CA$-5.23 Million minus capex CA$3.09K) represents -1% of total liabilities (CA$5.74 Million). Check strategic asset allocation of Cardiol Therapeutics Inc Class A to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cardiol Therapeutics Inc Class A Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Cardiol Therapeutics Inc Class A across 9 annual periods. See Cardiol Therapeutics Inc Class A (CRDL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cardiol Therapeutics Inc Class A (2017–2025)
Year-by-year free cash flow to debt coverage for Cardiol Therapeutics Inc Class A. For the full company profile including market capitalisation, see CRDL market cap.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | CA$-23.83 Million | CA$-23.85 Million | CA$5.74 Million | ▼ -18.3% |
| 2024 | -3.51x | CA$-25.04 Million | CA$-25.06 Million | CA$7.14 Million | ▼ -17.8% |
| 2023 | -2.98x | CA$-25.18 Million | CA$-25.18 Million | CA$8.45 Million | ▼ -7.8% |
| 2022 | -2.76x | CA$-27.15 Million | CA$-27.22 Million | CA$9.83 Million | ▼ -36.6% |
| 2021 | -2.02x | CA$-23.54 Million | CA$-23.55 Million | CA$11.64 Million | ▲ +42.0% |
| 2020 | -3.49x | CA$-9.14 Million | CA$-9.19 Million | CA$2.62 Million | ▲ +73.6% |
| 2019 | -13.19x | CA$-10.96 Million | CA$-11.38 Million | CA$830.83K | ▼ -192.2% |
| 2018 | -4.51x | CA$-10.88 Million | CA$-10.89 Million | CA$2.41 Million | ▼ -31.1% |
| 2017 | -3.44x | CA$-1.26 Million | CA$-1.29 Million | CA$366.76K | — |